A circadian and app-based personalized lighting intervention for the reduction of cancer-related fatigue

Lighting interventions can mitigate fatigue by promoting circadian rhythmicity. We test whether individualized, wearable-based lighting interventions delivered via a mobile app reduce cancer-related fatigue in a randomized controlled trial with 138 breast cancer, prostate cancer, and hematopoietic stem cell transplant patients. Participants are randomized to tailored lighting intervention or control. The primary endpoint is PROMIS fatigue 4a at trial end, with secondary endpoints including change in daily fatigue, sleep, anxiety, depression, physical function, and overall health. Fatigue T-scores at week 11 do not differ between groups but decrease significantly from week 1 to week 11 (3.07 points, p = 0.001) in the intervention group, with a significant final-week treatment effect (p = 0.014). Daily fatigue, anxiety, sleep disturbance, and physical function improve within intervention. Further studies are needed to see if these results generalize in broader cancer care. The trial is registered at ClinicalTrials.gov (trial registration number: NCT04827446).

Authors

Institutions

Publication Details

Journal
Cell Reports Medicine
Published
2025-03-01
DOI
https://doi.org/10.1016/j.xcrm.2025.102001
Citations
4
Primary Topic
Circadian rhythm and melatonin
Type
article
Field-Weighted Citation Impact
3.66

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A circadian and app-based personalized lighting intervention for the reduction of cancer-related fatigue

Olivia Walch, Caleb Mayer, Kevin M. Hannay, Caroline Clingan et al.
4 citations
Cell Reports Medicine
Circadian rhythm and melatonin
3.66
article

A circadian and app-based personalized lighting intervention for the reduction of cancer-related fatigue

Olivia Walch, Caleb Mayer, Kevin M. Hannay, Caroline Clingan, Walter Dempsey, Michelle Lois Rozwadowski, Joshi J. Alumkal, Sung Won Choi, N. Lynn Henry, Muneesh Tewari, Daniel B. Forger, Zachery R. Reichert, Zoe Bowen
article en
4 citations

Abstract

Lighting interventions can mitigate fatigue by promoting circadian rhythmicity. We test whether individualized, wearable-based lighting interventions delivered via a mobile app reduce cancer-related fatigue in a randomized controlled trial with 138 breast cancer, prostate cancer, and hematopoietic stem cell transplant patients. Participants are randomized to tailored lighting intervention or control. The primary endpoint is PROMIS fatigue 4a at trial end, with secondary endpoints including change in daily fatigue, sleep, anxiety, depression, physical function, and overall health. Fatigue T-scores at week 11 do not differ between groups but decrease significantly from week 1 to week 11 (3.07 points, p = 0.001) in the intervention group, with a significant final-week treatment effect (p = 0.014). Daily fatigue, anxiety, sleep disturbance, and physical function improve within intervention. Further studies are needed to see if these results generalize in broader cancer care. The trial is registered at ClinicalTrials.gov (trial registration number: NCT04827446).

Cell Reports MedicineVol. 6(3)
University of Michigan (US), Michigan Medicine (US), Michigan Center for Translational Pathology (US), Institute for Social Research (NO), Stanford University (US)
University of Michigan, National Cancer Institute
Openalex Percentile: Top 8%
Circadian rhythm and melatonin
3.66
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.